Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0P2IW
|
||||
Former ID |
DCL000286
|
||||
Drug Name |
Peramivir
|
||||
Synonyms |
BCZ; PeramiFlu; Rapiacta; BCX 1812; BCX1812; RWJ 270201; RWJ270201; BCX-1812; RWJ-270201; S-021812; (1S,2S,3S,4R)-3-(1-acetamido-2-ethylbutyl)-4-(diaminomethylideneamino)-2-hydroxycyclopentane-1-carboxylic acid; (1S,2S,3S,4R)-3-[(1S)-1-acetamido-2-ethylbutyl]-4-(diaminomethylideneamino)-2-hydroxycyclopentane-1-carboxylic acid; 3-(1'-acetylamino-2'-ethyl)butyl-4-((aminoimino)methyl)amino-2-hydroxycyclopentane-1-carboxylic acid; 3-(1-ACETYLAMINO-2-ETHYL-BUTYL)-4-GUANIDINO-2-HYDROXY-CYCLOPENTANECARBOXYLIC ACID; PRV
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Influenza virus [ICD10:J11.1] | Approved | [533123] | ||
Company |
BioCryst Pharmaceuticals
|
||||
Structure |
Download2D MOL |
||||
Formula |
C15H28N4O4
|
||||
Canonical SMILES |
CCC(CC)C(C1C(CC(C1O)C(=O)O)N=C(N)N)NC(=O)C
|
||||
InChI |
1S/C15H28N4O4/c1-4-8(5-2)12(18-7(3)20)11-10(19-15(16)17)6-9(13(11)21)14(22)23/h8-13,21H,4-6H2,1-3H3,(H,18,20)(H,22,23)(H4,16,17,19)/t9-,10+,11+,12?,13+/m0/s1
|
||||
InChIKey |
XRQDFNLINLXZLB-GKWMMFDUSA-N
|
||||
CAS Number |
CAS 229614-55-5
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Drug Resistance Mutation (DRM) | |||||
DRM | DRM Info | ||||
Target and Pathway | |||||
Target(s) | Neuraminidase | Target Info | Inhibitor | [536654], [536970] | |
KEGG Pathway | Other glycan degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.